Published in Medical Letter on the CDC and FDA, August 10th, 2008
Prior to joining PPD, Dr. Dingivan spent 12 years with MedImmune, a worldwide biologics business acquired by AstraZeneca PLC in 2007. She most recently served as senior vice president of clinical development and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA